Ceren Yıldız Eren, Özlem Özgür Gürsoy, Hulusi Göktuğ Gürer, Ramazan Bayırlı

Servikal kanser taramasında saptanan önemi belirlenemeyen atipik skuamoz hücrelerin klinik öneminin değerlendirmesi: Eskişehir deneyimi

Gereç ve yöntem: Araştırmaya Ocak 2011-Mayıs 2020 tarihleri arasında pap smear test sonucu atipik squamoz hücreler çıkan, kolposkopik biyopsi ile Human Papilloma Virüs (HPV) DNA genotip tayini yapılan 177 hasta dahil edilmiştir. Olguların kolposkopik bulguları Reid Kolposkopi İndeksine göre sınıflandırıp histopatoloji sonuçları ile karşılaştırılmıştır. Bulgular: İncelenen 177 hastada yaş ortalaması 37,1±1,41 yıl, parite 2,8±1,07 (0-11) ve ortalama sigara kullanımı 6 adet/gündür (0-40 adet/gün). Olguların 148'i (%83,6) premenopoz, 29'u (%16,3) postmenopoz dönemdedir. Kolposkopi eşliğinde biyopsi yapılan 68 olguya (%38,4) kronik servisit teşhisi konmuş olup, geriye kalan 108 (%61,0) hastada servikal intraepitelyal lezyonlar ve 1 (%0,5) olguda da servikal karsinom tespit edilmiştir. Hastaların HPV DNA tiplendirme ve Reid Kolposkopi İndeksi ile biyopsi sonuçları karşılaştırıldığında Fisher Kesin Olasılık Testi ile gruplar arasında istatiksel olarak anlamlı farklılık bulunmuştur (p

Evaluation of the clinical significance of atypical squamous cells, whose significance could not be determined in cervical cancer screening: Eskişehir experience

Purpose: The aim of our study is to determine the clinical importance of the diagnosis of atypical squamous cells. Materials and methods: Between January 2011 and May 2020, 177 patients with atypical squamous cells as a result of pap smear test and Human Papilloma Virus (HPV) DNA genotype determination by colposcopic biopsy were included in the study. The colposcopic results of the cases were classified according to the Reid Colposcopy Index and compared with the histopathology results. Results: In the 177 patients examined, the mean age was 37.1±1.41 year, parity was 2.8±1.07 (0-11), and the mean smoking was 6 units/day (0-40 units/day). 148 of the cases (83.6%) were in the premenopausal period and 29 (16.3%) were in the postmenopausal period. Chronic cervicitis was diagnosed in 68 cases (38.4%) who underwent colposcopy-guided biopsy, cervical intraepithelial lesions were detected in the remaining 108 (61.0%) patients, and cervical carcinoma was detected in 1 (0.5%) case. When the biopsy results of the patients were compared with HPV DNA typing and Reid Colposcopy Index, statistically significant difference was found between the groups with Fisher Exact Test. (p

PDF

___

1. Zekioglu O, Ozdemir N. Serviks kanserleri patolojisi. Turkiye Klinikleri J Med Oncol Special Topics 2011;4:14-19.
2. Ortac F, Taskın S. Serviksin malign hastalıkları. Turkiye Klinikleri J Surg Med Sci 2007;3:55-58.
3. GCO Cancer, IARC Globocan 2018: estimated cancer incidence, mortality and prevalence worldwide in 2018. Available at: http://gco.iarc.fr/today/explore. Accessed Dec 14, 2020
4. Qiao YL. Perspective of cervical cancer prevention and control in developing countries and areas. Chin J Cancer 2010;29:1-3. https://doi.org/10.5732/ cjc.009.10570
5. Ozan H. Servikal karsinogeneziste HPV’nin rolü. Turkiye Klinikleri J Gynecol Obst-Special Topics 2009;2:9-12.
6. Kitchener HC, Castle PE, Cox JT. Chapter 7: achievements and limitations of cervical cytology screening. Vaccine 2006;24:63-70. https://doi. org/10.1016/j.vaccine.2006.05.113
7. ACOG practice bulletin no 99: management of abnormal cervical cytology and histology. Obstet Gynecol 2008;112:1419-1444. https://doi.org/10.1097/ AOG.0b013e318192497c
8. Türkiye Kanser Kontrol Programı. T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu Kanser Daire Başkanlığı. Erişim adresi: https://hsgm.saglik.gov.tr/depo/birimler/ kanser-db/yayinlar/raporlar/Ulusal_Kanser_Kontrol_ Plani_2013_2018.pdf. Erişim tarihi 14 Aralık 2020
9. Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol 2015;136:178-182. https://doi.org/10.1016/j. ygyno.2014.12.022
10. Burghardt E, Histopathologic basis of colposcopy. In: Colposcopy Cervical Pathology Textbook and Atlas, 4th ed. New York, NY: Georg Thieme Verlag 2015;24- 56.
11. Saslow D, Solomon D, Lawson HW, et al. American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012;137:516-542. https://doi.org/10.1309/ AJCPTGD94EVRSJCG
12. Mitchell MF, Schottenfeld D, Tortolero Luna G, Cantor SB, Richards Kortum R. Colposcopy for the diagnosis of squamous intraepithelial lesions: a metaanalysis. Obstet Gynecol 1998;91:626-631. https://doi. org/10.1016/S0029-7844(98)00006-4
13. Cantor SB, Cárdenas Turanzas M, Cox DD, et al. Accurary of colposcopy in the diagnostic setting compared with the screening setting. Obstet Gynecol 2008;111:7-14. https://doi.org/10.1097/01. AOG.0000295870.67752.b4
14. Auger M, Charbonneau M, Arseneau J. Atypical squamous cells of undetermined significance. A cytohistologic study of 52 cases. Acto Cytol 1997;41:1671-1675. https://doi. org/10.1159/000333166
15. ALTS Group. A randomized trial on the management of lowgrade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393- 1400. https://doi.org/10.1067/mob.2003.462
16. Tamburacı Demir E, Ceyhan M, Simsek M, et al. The prevalence of different HPV types in Turkish women with a normal pap smear. J Med Virol 2012;84:1242- 1247. https://doi.org/10.1002/jmv.23333
17. Castle PE, Wacholder S, Lorincz AT, et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 2002;94:1406-1414. https://doi.org/10.1093/ jnci/94.18.1406
18. Sarian LO, Hammes LS, Longatto Filho A, et al. Increased risk of oncogenic human papillomavirus infections and incident high-grade cervical intraepithelial neoplasia among smokers: experience from the Latin American screening study. Sex Transm Dis 2009:36;241-248. https://doi.org/10.1097/ OLQ.0b013e3181935a7d
19. Rijkaart DC, Berkhof J, Rozendaal L, et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol 2012;13:78-88. https://doi.org/10.1016/ S1470-2045(11)70296-0
20. Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2020;24:102- 131. https://doi.org/10.1097/LGT.0000000000000525
21. Bruno MT, Cassaro N, Bica F, Boemi S. Progression of CIN1/LSIL HPV persistent of the cervix: actual progression or CIN3 coexistence. Infect Dis Obstet Gynecol 2021:1-6. https://doi. org/10.1155/2021/6627531
22. Ciavattini A, Serri M, Di Giuseppe J, et al. Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study. BMJ Open 2019;9:e024920. https://doi.org/10.1136/ bmjopen-2018-024920